Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cariogenic oral bacteria are a group of microorganisms in the oral cavity, most notably *Streptococcus mutans*, *Streptococcus sobrinus*, and *Lactobacillus* species, that metabolize dietary sugars to produce acids[1][4][5]. These acids reduce local pH and lead to the demineralization of tooth enamel, initiating and promoting dental caries[1][4]. Cariogenic bacteria colonize the tooth surface, form biofilms (dental plaque), and are sustained by frequent carbohydrate intake. Interactions among these microbes, along with certain fungi (e.g., *Candida albicans*), can exacerbate cariogenicity[1][2]. While "Cariogenic oral bacteria" is a functional and clinical concept, it does not constitute a single, structurally defined molecular target for therapeutic intervention. Instead, it is a collective description of a pathogenic microbial community[1][2][3][4][5].
Disruption of bacterial biofilm - Inhibition of bacterial sugar metabolism or acid production - Inhibition of bacterial adhesion to enamel - Direct antibacterial/bactericidal action
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cariogenic oral bacterium.